Heart Attack Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Heart Attack stocks.

Heart Attack Stocks Recent News

Date Stock Title
Apr 24 BMY Bristol-Myers Earnings Preview: Major near-term headwinds invites worries about Q1 results
Apr 24 BMY What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Apr 23 BMY S&P 500 stocks with biggest estimated EPS declines for Q1
Apr 23 BMY NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Apr 23 BMY Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook
Apr 23 BMY Former Bristol Myers CEO tapped as Novartis’ next board chair
Apr 22 BMY Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Apr 22 BMY Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal
Apr 22 BMY Is Bristol Myers Squibb A Buy At These Bottom Levels?
Apr 22 BMY Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Apr 22 BMY Bristol Myers taps startup to boost cell therapy production
Apr 22 BMY Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Apr 21 BMY Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 21 BMY Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
Apr 20 BMY 3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations
Apr 19 BMY Got $500? 3 Healthcare Stocks to Buy and Hold Forever
Apr 19 BMY FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
Apr 18 BMY Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Heart Attack

Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Often it occurs in the center or left side of the chest and lasts for more than a few minutes. The discomfort may occasionally feel like heartburn. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, or feeling tired. About 30% of people have atypical symptoms. Women more often present without chest pain and instead have neck pain, arm pain, or feel tired. Among those over 75 years old, about 5% have had an MI with little or no history of symptoms. An MI may cause heart failure, an irregular heartbeat, cardiogenic shock, or cardiac arrest.Most MIs occur due to coronary artery disease. Risk factors include high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol intake, among others. The complete blockage of a coronary artery caused by a rupture of an atherosclerotic plaque is usually the underlying mechanism of an MI. MIs are less commonly caused by coronary artery spasms, which may be due to cocaine, significant emotional stress, and extreme cold, among others. A number of tests are useful to help with diagnosis, including electrocardiograms (ECGs), blood tests, and coronary angiography. An ECG, which is a recording of the heart's electrical activity, may confirm an ST elevation MI (STEMI) if ST elevation is present. Commonly used blood tests include troponin and less often creatine kinase MB.Treatment of an MI is time-critical. Aspirin is an appropriate immediate treatment for a suspected MI. Nitroglycerin or opioids may be used to help with chest pain; however, they do not improve overall outcomes. Supplemental oxygen is recommended in those with low oxygen levels or shortness of breath. In a STEMI, treatments attempt to restore blood flow to the heart, and include percutaneous coronary intervention (PCI), where the arteries are pushed open and may be stented, or thrombolysis, where the blockage is removed using medications. People who have a non-ST elevation myocardial infarction (NSTEMI) are often managed with the blood thinner heparin, with the additional use of PCI in those at high risk. In people with blockages of multiple coronary arteries and diabetes, coronary artery bypass surgery (CABG) may be recommended rather than angioplasty. After an MI, lifestyle modifications, along with long term treatment with aspirin, beta blockers, and statins, are typically recommended.Worldwide, about 15.9 million myocardial infarctions occurred in 2015. More than 3 million people had an ST elevation MI and more than 4 million had an NSTEMI. STEMIs occur about twice as often in men as women. About one million people have an MI each year in the United States. In the developed world the risk of death in those who have had an STEMI is about 10%. Rates of MI for a given age have decreased globally between 1990 and 2010. In 2011, a MI was one of the top five most expensive conditions during inpatient hospitalizations in the US, with a cost of about $11.5 billion for 612,000 hospital stays.

Browse All Tags